Text version
Greetings, David Rosenberg here. In this CAP Smart Take, we will examine an overlooked but crucial area in child and adolescent psychiatry: Remission and relapse during long–term follow–up—specifically, a 3–year follow-up—of pediatric patients diagnosed with obsessive-compulsive disorder (OCD). This study is remarkable in many respects.
The authors studied remission and relapse rates over a 3-year period in pediatric patients with OCD treated with state-of-the-art medication, including cognitive–behavior therapy (CBT) as the first step. If necessary, they continued CBT or received sertraline as a second step. They analyzed a large sample of nearly 270 patients who met DSM-IV criteria for OCD. The average Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) score was 25, with scores of 17 or higher indicating significant dysfunction. The results were captivating; approximately one-third of the patients maintained stable and full remission throughout all assessments.
Patients who achieved remission following treatment displayed mild OCD symptoms but generally did well
Unlock this CAP Smart Take and earn 0.50 CMEs
Become a Silver, Gold, Silver extended or Gold extended Member.
Already have an account? Sign in
